Literature DB >> 1671863

Full length and alternatively spliced pgp1 transcripts in multidrug-resistant Chinese hamster lung cells.

S E Devine1, A Hussain, J P Davide, P W Melera.   

Abstract

In an effort to better understand the preferential resistance to actinomycin D displayed by the multidrug-resistant Chinese hamster lung cell line DC-3F/ADX, we have cloned from those cells a number of cDNAs representing p-glycoprotein gene transcripts. Of the 12 clones isolated, all represent pgp1 transcripts and one, pADX165, contains a 4304-base pair insert with an open reading frame encoding a 1276-amino acid protein that is the homolog of the mouse mdr3/mdr1a gene product. A domain by domain comparison of this protein with p-glycoproteins capable of supporting multidrug resistance, i.e. human mdr1, mouse mdr1/mdr1b, and mouse mdr3/mdr1a, shows that, in addition to the ATP binding sites, the second, fourth, and eleventh transmembrane domains and the four small intracellular loops, IC-1, IC-2, IC-4, and IC-5, are highly conserved and are therefore likely to be important for the maintenance of p-glycoprotein function. Of the remaining 11 cDNA clones, 9 were found to be truncated versions of pADX165. Two others, however, pADX185 and pADX124, contained internal deletions resulting in open reading frames capable of encoding lnovel forms of p-glycoprotein. S1 nuclease and RNase protection analysis demonstrated that these cDNAs represent transcripts present in a number of different multidrug-resistant Chinese hamster lung cell lines. Hence, both are considered to be splicing variants of the hamster pgp1 gene primary transcript.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671863

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Differential utilization of poly (A) signals between DHFR alleles in CHL cells.

Authors:  K W Scotto; H Yang; J P Davide; P W Melera
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

Review 2.  Molecular analysis of the multidrug transporter.

Authors:  U A Germann
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human P-glycoprotein.

Authors:  T C Chambers; J Pohl; D B Glass; J F Kuo
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

4.  De novo generation of simple sequence during gene amplification.

Authors:  L S Kirschner
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

5.  P-glycoprotein is not a swelling-activated Cl- channel; possible role as a Cl- channel regulator.

Authors:  C G Vanoye; G A Altenberg; L Reuss
Journal:  J Physiol       Date:  1997-07-15       Impact factor: 5.182

6.  Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance.

Authors:  S E Devine; V Ling; P W Melera
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Functional studies with a full-length P-glycoprotein cDNA encoded by the hamster pgp1 gene.

Authors:  S E Devine; P W Melera
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT.

Authors:  E Roundhill; S Burchill
Journal:  Br J Cancer       Date:  2013-06-25       Impact factor: 7.640

9.  Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

Authors:  C K van Kalken; H J Broxterman; H M Pinedo; N Feller; H Dekker; J Lankelma; G Giaccone
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

10.  Reporter dyes demonstrate functional expression of multidrug resistance proteins in the marine flatworm Macrostomum lignano: the sponge-derived dye Ageladine A is not a substrate of these transporters.

Authors:  Kristin Tietje; Georgina Rivera-Ingraham; Charlotte Petters; Doris Abele; Ralf Dringen; Ulf Bickmeyer
Journal:  Mar Drugs       Date:  2013-10-16       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.